The Army’s Quick Cure - Science & Technology - magz.tempo.co

maaf email atau password anda salah

The Army’s Quick Cure

Monday, August 24, 2020

Research for a Covid-19 drug by Airlangga University sparked a polemic. Aside from its effectiveness, its adherence to clinical trials protocol is also questioned. The ball is now in the Indonesia Food and Drug Authority’s court.

. tempo : 177901832021.

THE Rector of Airlangga University (Unair), Mohammad Nasih, hurried to the E Building in the Indonesian Army Headquarters in Jalan Veteran, Central Jakarta, on Saturday, August 15. He was there to deliver the phase III clinical trial result of a Covid-19 drug to the Army—which is sponsoring the research, alongside the State Intelligence Agency (BIN). “Of course, since this will be a new drug, it is expected to be the first Covid-19 cu

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 750.000/12 months

*Flexible payment methods
*Unlimited access to Tempo Plus & Tempo Magz

Subscribe

Rp 386.280/6 months

*Auto-renews every 6 months
*Cancel at anytime
*Unlimited access to Tempo Plus & Tempo Magz

Subscribe

See Other Packages

Already a Subscribed?
To receive daily news by Email,

More Articles

Tempo English Monday, August 24, 2020
Tempo English Monday, August 24, 2020
Tempo English Monday, August 24, 2020
Tempo English Monday, August 24, 2020

More exclusive contents

May 11, 2026
May 4, 2026
April 27, 2026
April 20, 2026

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.